Laura D. Gamble

Also affiliated with Cancer Institute (WIA), Cancer Institute of New South Wales, UNSW Sydney, Children's Cancer Institute Australia, NIHR Exeter Clinical Research Facility, Newcastle University

MedicineHealth ProfessionsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma”.

A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma

Cancers(2021)10.3390/cancers13081807

N/A

0DataRank · unranked

6 citations

Stefania Purgato, Michelle J. Henderson, Simone Di Giacomo, Amanda J. Russell, Paolo Pigini +30 more

The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2420011122

N/A

0DataRank · unranked

4 citations

Chengyuan Xue, Laura D. Gamble, Giorgio Milazzo, Simone Di Giacomo, Jayne Murray +21 more